Optical imaging of the breast

Cancer Imaging

Volumn 8, Issue 1, 2008, Pages 206-215

  Van De Ven, S M W Y ^a   Elias, S G ^a   Van Den Bosch, M A A J ^a   Luijten, P ^a   Mali, W PTh M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Absorption; Breast cancer; Fluorescence; Molecular imaging; Optical imaging

Indexed keywords

CONTRAST MEDIUM;

ARTICLE; BREAST TUMOR; DIAGNOSTIC IMAGING; FEMALE; HUMAN; METHODOLOGY; NEAR INFRARED SPECTROSCOPY; TREATMENT OUTCOME;

BREAST NEOPLASMS; CONTRAST MEDIA; DIAGNOSTIC IMAGING; FEMALE; HUMANS; SPECTROSCOPY, NEAR-INFRARED; TREATMENT OUTCOME;

EID: 65849357383     PISSN: None     EISSN: 14707330     Source Type: Journal    
DOI: 10.1102/1470-7330.2008.0032     Document Type: Review

References (51)

1. Garcia M, Jemal A, Ward EM, et al. Global cancer facts & figures 2007. Atlanta, GA, American Cancer Society; 2007.
2. Fletcher SW, Elmore JG. Clinical practice. Mammographie screening for breast cancer. N Engl J Med 2003; 348: 1672-80. (Pubitemid 36459474)
3. Humphrey LL, Helfand M, Chan BK, Woolf SH. Breast cancer screening: a summary of the evidence for the US Preventive Services Task Force. Ann Intern Med 2002; 137: 347-60. (Pubitemid 34977137)
4. Buist DS, Porter PL, Lehman C, Taplin SH, White E. Factors contributing to mammography failure in women aged 40-49 years. J Natl Cancer Inst 2004; 96: 1432-40. (Pubitemid 39429667)
5. Carney PA, Miglioretti DL, Yankaskas BC, et al. Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med 2003; 138: 168-75. (Pubitemid 36231622)
6. Boyd NF, Guo H, Martin LJ, et al Mammographie density and the risk and detection of breast cancer. N Engl J Med 2007; 356: 227-36. (Pubitemid 46143226)
7. Cutler M. Transillumination as an aid in the diagnosis of breast lesions. Surg Gynecol Obstet 1929; 48: 721-8.
8. Gibson AP, Hebden JC, Arridge SR. Recent advances in diffuse optical imaging. Phys Med Biol 2005; 50: Rl-43.
9. Arridge SR, Schweiger M. Image reconstruction in optical tomography. Philos Trans R Soc Lond B Biol Sci 1997; 352: 717-26. (Pubitemid 27354103)
10. Schweiger M, Arridge SR, Nissila I. Gauss-Newton method for image reconstruction in diffuse optical tomography. Phys Med Biol 2005; 50: 2365-86. (Pubitemid 40767821)
11. Schweiger M, Nissila I, Boas DA, Arridge SR. Image reconstruction in optical tomography in the presence of coupling errors. Appl Opt 2007; 46: 2743-56. (Pubitemid 46955646)
12. Arridge SR Hiraoka M, Schweiger M. Statistical basis for the determination of optical pathlength in tissue. Phys Med Biol 1995; 40: 1539-58.
13. Franceschini MA, Moesta KT, Fantini S, et al. Frequency-domain techniques enhance optical mammography: initial clinical results. Proc Natl Acad Sci U S A 1997; 94: 6468-73. (Pubitemid 27270708)
14. Götz L, Heywang-Kobrunner SH, Schutz O, Siebold H. [Optical mammography in preoperative patients]. Akt Radiol 1998; 8: 31-3.
15. Rinneberg H, Grosenick D, Moesta KT, et al Scanning timedomain optical mammography: detection and characterization of breast tumors in vivo. Technol Cancer Res Treat 2005; 4: 483-96. (Pubitemid 41446802)
16. Taroni P, Torricelli A, Spinelli L, et al Time-resolved optical mammography between 637 and 985 nm: clinical study on the detection and identification of breast lesions. Phys Med Biol 2005; 50: 2469-88. (Pubitemid 40770634)
17. Tomandl B, Doinghaus K, Schulz-Wendtland R. [Laser mammography with near-infrared light]. Rontgenpraxis 1995; 48: 197-201.
18. Floery D, Helbich TH, Riedl CC, et al Characterization of benign and malignant breast lesions with computed tomography laser mammography (CTLM): initial experience. Invest Radiol 2005; 40: 328-35. (Pubitemid 40734560)
19. Yates T, Hebden JC, Gibson A, Everdell N, Arridge SR, Douek M. Optical tomography of the breast using a multi-channel time-resolved imager. Phys Med Biol 2005; 50: 2503-17. (Pubitemid 40770636)
20. Zhu Q, Cronin EB, Currier AA, et al Benign versus malignant breast masses: optical differentiation with US-guided optical imaging reconstruction. Radiology 2005; 237: 57-66. (Pubitemid 41346146)
21. Chance B, Nioka S, Zhang J, et al Breast cancer detection based on incremental biochemical and physiological properties of breast cancers: a six-year, two-site study. Acad Radiol 2005; 12: 925-33. (Pubitemid 41116409)
22. Hsiang D, Shah N, Yu H, et al Coregistration of dynamic contrast enhanced MRI and broadband diffuse optical spectroscopy for characterizing breast cancer. Technol Cancer Res Treat 2005; 4: 549-58. (Pubitemid 41446807)
23. Intes X. Time-domain optical mammography Soft Scan: initial results. Acad Radiol 2005; 12: 934-47. (Pubitemid 41116410)
24. Ntziachristos V, Yodh AG, Schnall MD, Chance B. MRI-guided diffuse optical spectroscopy of malignant and benign breast lesions. Neoplasia 2002; 4: 347-54. (Pubitemid 34755845)
25. Nissila I, Hebden JC, Jennions D, et al. Comparison between a time-domain and a frequency-domain system for optical tomography. J Biomed Opt 2006; 11: 064015.
26. Siegel A, Marota JJ, Boas D. Design and evaluation of a continuous-wave diffuse optical tomography system. Opt Express 1999; 4: 287-98.
27. Arridge SR, Lionheart WR. Nonuniqueness in diffusion-based optical tomography. Opt Lett 1998; 23: 882-4. (Pubitemid 128590546)
28. van de Ven SM, Wiethoff AJ, van der Voort M, et al. Spectroscopic diffuse optical imaging of the breast: first clinical experiences in the characterization of cysts. Joint Molecular Imaging Conference 2007, Providence, RI. Academy of Molecular Imaging & Society for Molecular Imaging.
29. Rice A, Quinn CM. Angiogenesis, thrombospondin, and ductal carcinoma in situ of the breast. J Clin Pathol 2002; 55: 569-74.
30. Vaupel P, Harrison L. Tumor hypoxia: causative factors, compensatory mechanisms, and cellular response. Oncologist 2004; 9: 4-9. (Pubitemid 39658340)
31. Gu X, Zhang Q, Bartlett M, Schutz L, Fajardo LL, Jiang H. Differentiation of cysts from solid tumors in the breast with diffuse optical tomography. Acad Radiol 2004; 11: 53-60. (Pubitemid 38029820)
32. Cerussi A, Hsiang D, Shah N, et al. Predicting response to breast cancer neoadjuvant chemotherapy using diffuse optical spectroscopy. Proc Natl Acad Sci U S A 2007; 104: 4014-19. (Pubitemid 47181570)
33. Cerussi A, Shah N, Hsiang D, Durkin A, Butler J, Tromberg BJ. In vivo absorption, scattering, and physiologic properties of 58 malignant breast tumors determined by broadband diffuse optical spectroscopy. J Biomed Opt 2006; 11: 044005.
34. Durduran T, Choe R, Yu G, et al. Diffuse optical measurement of blood flow in breast tumors. Opt Lett 2005; 30: 2915-17. (Pubitemid 41654993)
35. Bremer C, Ntziachristos V, Weitkamp B, Theilmeier G, Heindel W, Weissleder R. Optical imaging of spontaneous breast tumors using protease sensing 'smart' optical probes. Invest Radiol 2005; 40: 321-7. (Pubitemid 40734559)
36. Bremer C, Tung CH, Bogdanov Jr A, Weissleder R. Imaging of differential protease expression in breast cancers for detection of aggressive tumor phenotypes. Radiology 2002; 222: 814-18. (Pubitemid 34218157)
37. Mahmood U, Tung CH, Bogdanov Jr A, Weissleder R. Nearinfrared optical imaging of protease activity for tumor detection. Radiology 1999; 213: 866-70.
38. Wang LV. Optical tomography for biomedical applications. IEEE Eng Med Biol Mag 1998; 17: 45-6.
39. Hilger I, Leistner Y, Berndt A, et al. Near-infrared fluorescence imaging of HER-2 protein over-expression in tumour cells. Eur Radiol 2004; 14: 1124-9. (Pubitemid 38787258)
40. Ke S, Wen X, Gurfinkel M, et al. Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts. Cancer Res 2003; 63: 7870-5. (Pubitemid 37466721)
41. Montet X, Ntziachristos V, Grimm J, Weissleder R. Tomographic fluorescence mapping of tumor targets. Cancer Res 2005; 65: 6330-6. (Pubitemid 40994419)
42. Sampath L, Kwon S, Ke S, et al. Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancer. J Nucl Med 2007; 48: 1501-10. (Pubitemid 47397400)
43. Yang M, Baranov E, Li XM, et al. Whole-body and intravital optical imaging of angiogenesis in orthotopically implanted tumors. Proc Natl Acad Sci U S A 2001; 98: 2616-21. (Pubitemid 32209531)
44. Wang W, Ke S, Kwon S, et al. A new optical and nuclear duallabeled imaging agent targeting interleukin 11 receptor alphachain. Bioconjug Chem 2007; 18: 397-402. (Pubitemid 46493510)
45. Yang Z, Zheng S, Harrison WJ, et al. Long-circulating nearinfrared fluorescence core-cross-linked polymeric micelles: synthesis, characterization, and dual nuclear/optical imaging. Biomacromolecules 2007; 8: 3422-8. (Pubitemid 350193742)
46. Intes X, Ripoll J, Chen Y, Nioka S, Yodh AG, Chance B. In vivo continuous-wave optical breast imaging enhanced with Indocyanine Green. Med Phys 2003; 30: 1039-47. (Pubitemid 36735969)
47. Ntziachristos V, Yodh AG, Schnall M, Chance B. Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement. Proc Natl Acad Sei U S A 2000; 97: 2767-72. (Pubitemid 30159246)
48. Lehman CD, Isaacs C, Schnall MD, et al. Cancer yield of mammography, MR, and US in high-risk women: prospective multi-institution breast cancer screening study. Radiology 2007; 244: 381-8. (Pubitemid 47080869)
49. Lehman CD, Gatsonis C, Kuhl CK, et al MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med 2007; 356: 1295-303. (Pubitemid 46513295)
50. Liberman L, Mason G, Morris EA, Dershaw DD. Does size matter? Positive predictive value of MRI-detected breast lesions as a function of lesion size. AJR Am J Roentgenol 2006; 186: 426-30. (Pubitemid 46100312)
51. Mankoff DA. A definition of molecular imaging. J Nucl Med 2007; 48: 18N, 21N.